News

Autodesk's (NASDAQ: ADSK) stock plunged 15% on Nov. 24 after the design software maker posted its third-quarter earnings report.

Its revenue rose 18% year-over-year to $1.13 billion, which beat

Moderna (NASDAQ: MRNA) has proved itself when it comes to handling the original coronavirus and the variants that have emerged since the beginning of the year. The biotech company's vaccine has

Keysight Technologies (NYSE: KEYS) may not be a household name as compared to well-known companies such as Apple, Qualcomm, or Broadcom in the fifth-generation (5G) wireless network space, but it

Millions of seniors rely on Medicare for health coverage during retirement. But one major myth surrounding the program is that it's free, or at least inexpensive.

Not so. Between premiums

Shiba Inu (CRYPTO: SHIB) skyrocketed to an all-time high in October, rising more than 153,000,000% from its 52-week low on Nov. 28, 2020. However, the meme token has since lost nearly half of its

Vertex Pharmaceuticals (NASDAQ: VRTX) has given more than one investor a headache over the past year. The company's shares have suffered ever since the company announced the failure of two

Want to know two amounts that just might blow you away? Here they are -- $2.07 and $675.67. To be blown away, though, you need to understand the context.

If you had invested only $2.07 one year ago

Despite the shortened hours, Friday, Nov. 26 represented a bumpy ride for investors. All three of the major indexes shed between 2.2% and 2.5% of their value as a new coronavirus variant of concern

For many investors with a long-term focus, few strategies work as well as one of the simplest ones out there: dollar-cost averaging into a low-cost index fund. Kept up over the course of a career

It's been an absolutely incredible year for Shiba Inu (CRYPTO: SHIB). The cryptocurrency may have started as something of a joke, but it's gone on to become one of the most explosive winners in

If you think the rally from the coronavirus pandemic bottom has been stellar for Wall Street, you should take a closer look at the gains from the cryptocurrency space. In a roughly 20-month stretch

Millions of seniors become dependent on Social Security once they stop working and enter retirement. And even if you amass a pretty nice-sized nest egg, you may still end up depending heavily on

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Remember when

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

What is Twitter

The recent ruling by the South Dakota Supreme Court that struck down a voter referendum approving legalized marijuana shows the difficult road ahead for cannabis stocks in dealing with

Patient, long-term investors tend to do better in the stock market than those who flit in and out of the market, as the S&P 500 has risen almost 270% over the past decade and sets new records almost

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Here comes déjà

Plenty of high-growth tech stocks have been hit hard in 2021 despite stellar business performances. Upstart was recently cut in half in a matter of weeks, while Pinterest has had a slow, painful

I went bargain hunting last week. I bought shares of Dick's Sporting Goods (NYSE: DKS) and added to my existing position in Genius Sports (NYSE: GENI) on Tuesday. The two stocks were falling after

Black Friday wasn't kind to U.S. stocks. Every major U.S. stock index fell by more than 2% on the holiday-shortened trading session due to concerns about the omicron coronavirus variant. Although it

The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might

Biopharmaceutical stocks are slated to end the year on a sour note. Apart from top COVID-19 vaccine players like Pfizer, Moderna, and Novavax, investors have shown little to no interest in owning

Wall Street analysts set stock price targets and provide detailed insights on companies. However, their views are often short-sighted, capped by what they can put into their models. As a result

For better or worse, social media is a huge part of society. Billions of people interact with it daily, so advertisers spend heavily to better reach their intended audiences. Because of this, social

Rivian Automotive (NASDAQ: RIVN) burst on the scene earlier this month. The electric vehicle developer was worth more than $150 billion at one point despite not generating any meaningful revenue.